Tomohiro Matsuo Selected Research

Tomohiro Matsuo Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 04/2005
13	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 12/2006
12	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 08/2011
12	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021 - 01/2013
11	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2011
8	Overactive Urinary Bladder (Overactive Bladder) 07/2022 - 07/2016
6	Lower Urinary Tract Symptoms 03/2022 - 07/2016
5	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 12/2021
4	Disease Progression 01/2022 - 08/2014
4	Carcinogenesis 10/2021 - 01/2017
4	Spinal Cord Diseases 07/2021 - 08/2013
4	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 07/2021 - 08/2013
3	Urologic Neoplasms (Urological Cancer) 09/2023 - 10/2017
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2022 - 07/2019
3	Fatigue 10/2020 - 10/2015
3	Nocturia 04/2019 - 01/2017
2	Sarcopenia 02/2024 - 03/2021
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 01/2021
2	Renal Insufficiency (Renal Failure) 12/2021 - 01/2013
2	Anorexia 10/2020 - 12/2018
2	Pain (Aches) 10/2015 - 09/2012
1	Signet Ring Cell Carcinoma 04/2024
1	Thrombosis (Thrombus) 01/2024
1	Embolism (Embolus) 11/2023
1	Ulcer 11/2023
1	Fever (Fevers) 09/2023
1	Carcinoma (Carcinomatosis) 09/2023
1	Anemia 09/2023
1	Evans Syndrome 09/2023
1	Pelvic Neoplasms 09/2023
1	Constipation 07/2022
1	Hypertension (High Blood Pressure) 03/2022
1	Hypercalciuria 03/2022
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2022
1	Erectile Dysfunction 01/2022

Drug/Important Bio-Agent (IBA)

7	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 06/2011
6	Gemcitabine FDA Link 11/2019 - 06/2011
5	mirabegronIBA 07/2022 - 07/2016
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 12/2011
4	royal jellyIBA 12/2021 - 12/2018
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 12/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 01/2013
4	AntigensIBA 07/2018 - 01/2016
3	NivolumabIBA 04/2024 - 01/2022
3	Immune Checkpoint InhibitorsIBA 09/2023 - 04/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2017
3	Sunitinib (Sutent)FDA Link 01/2022 - 06/2018
3	ProstaglandinsIBA 10/2021 - 01/2013
3	Dinoprostone (PGE2)FDA Link 10/2021 - 12/2006
3	stage-specific embryonic antigen-4IBA 07/2021 - 10/2019
3	PolyphenolsIBA 01/2021 - 01/2017
3	SaltsIBA 01/2021 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 11/2020 - 12/2018
3	TeaIBA 08/2018 - 01/2017
2	IpilimumabIBA 04/2024 - 01/2024
2	pembrolizumabIBA 09/2023 - 01/2022
2	Macrophage Colony-Stimulating FactorIBA 12/2021 - 10/2020
2	8-Hydroxy-2'-DeoxyguanosineIBA 12/2021 - 08/2021
2	Malondialdehyde (Propanedial)IBA 12/2021 - 08/2021
2	Hormones (Hormone)IBA 09/2021 - 01/2016
2	Ceruloplasmin (Ferroxidase)IBA 08/2021 - 07/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 10/2017
2	Heme Oxygenase-1IBA 07/2020 - 01/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2020 - 01/2016
2	prosultiamineIBA 01/2018 - 08/2013
2	Vascular Endothelial Growth FactorsIBA 01/2017 - 01/2016
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017 - 01/2013
2	Formaldehyde (Formol)FDA Link 11/2013 - 01/2013
1	C-Reactive ProteinIBA 04/2024
1	CholesterolIBA 11/2023
1	Rituximab (Mabthera)FDA Link 02/2023
1	fesoterodine FDA Link 07/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 07/2022
1	CalciumIBA 03/2022
1	enfortumab vedotinIBA 01/2022
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2022
1	Muscarinic AntagonistsIBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2022

Therapy/Procedure

23	Therapeutics 04/2024 - 06/2011
8	Nephrectomy 04/2024 - 04/2005
6	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 02/2012
4	Drug Therapy (Chemotherapy) 04/2020 - 06/2011
4	Aftercare (After-Treatment) 01/2018 - 09/2012
3	Kidney Transplantation 02/2024 - 07/2019
3	Activities of Daily Living (ADL) 02/2024 - 09/2023
3	Cardiac Rehabilitation 02/2024 - 03/2021
3	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 07/2019
3	Castration 09/2021 - 01/2016
2	Cystectomy 04/2024 - 01/2019
2	Renal Dialysis (Hemodialysis) 12/2021 - 06/2012
2	Combination Drug Therapy (Combination Chemotherapy) 12/2011 - 06/2011
1	Brachytherapy 02/2024
1	Neoadjuvant Therapy 01/2024
1	Thrombectomy 12/2023
1	Blood Transfusion (Blood Transfusions) 12/2023
1	Surgical Amputation (Amputations) 11/2023
1	Vascular Surgical Procedures 11/2023
1	Nephroureterectomy 09/2023